Results 251 to 260 of about 53,238 (282)

The Allosteric Regulator Inositol Phosphate Dramatically Affects the Efficacy and Selectivity of Inhibitors for Different HDAC Complexes. [PDF]

J Am Chem Soc
Pytel WA, Patel U, Smalley JP, Millard CJ, Brown EA, Pavan AR, Wang S, Kalin JH, Dos Santos JL, Cole PA, Hodgkinson JT, Schwabe JWR.   +11 more
europepmc   +1 more source

Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes. [PDF]

Pharmaceuticals (Basel)
Pinheiro PSM, Diniz LP, Franco LS, Siqueira M, Gomes FCA.   +4 more
europepmc   +1 more source

Genome-wide identification and multi-dimensional functional characterization of the SIR2 family in Brassica napus L. [PDF]

PLoS One
Hu H, He L, Chen R, Jing Z, Wan H, Xiao Z, Cheng H, Wu C, Liu X.   +8 more
europepmc   +1 more source

From modification to malignancy: Bridging acetylation mechanisms and therapeutic innovations in melanoma (Review). [PDF]

Oncol Rep
Wu J, Cai X, Zhu Z, Li X, Zhang K, Wu C, Yu B, Huang C.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Histone Deacetylase Inhibitors

ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Thomas A, Miller, David J, Witter, Sandro, Belvedere   +2 more
openaire   +2 more sources

Prospects: Histone deacetylase inhibitors

Journal of Cellular Biochemistry, 2005
AbstractHistone deacetylase (HDAC), inhibitors represent a new class of targeted anti‐cancer agents. Several of these compounds are in clinical trials with significant activity against a spectrum of both hematologic and solid tumors at doses that are well tolerated by the patients.
Milos, Dokmanovic, Paul A, Marks
openaire   +2 more sources

Histone deacetylase inhibitors

European Journal of Medicinal Chemistry, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire   +4 more sources